Verndari, Inc. Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Verndari, Inc. is a biotechnology research company focused on advancing vaccine development and delivery. Based in the Sacramento area, the privately held firm was founded in 2015 with the aim of addressing existing and emerging diseases, including pandemic threats, through next-generation vaccine technologies and methods of administration. The company has pursued approaches such as dermal delivery systems, exemplified by its VaxiPatch technology, and has conducted preclinical work on vaccines including COVID-19, reflecting its emphasis on rapid, scalable vaccine development for global health needs. With a small team, Verndari operates within the biotechnology research sector, seeking to provide new tools and platforms to improve vaccine accessibility and effectiveness. A recent development noted in public channels is a publication highlighting early data for a vaccine delivery system, underscoring ongoing research activity in its field.